Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.05 Million EUR | 146.13% |
| 2022 | -4.27 Million EUR | -229.79% |
| 2021 | -364 Thousand EUR | 704.23% |
| 2020 | -1.04 Million EUR | 46.88% |
| 2019 | -952 Thousand EUR | 73.35% |
| 2018 | -3.8 Million EUR | -53.08% |
| 2017 | -2.48 Million EUR | -6386.49% |
| 2016 | 544.99 Thousand EUR | 72.59% |
| 2015 | -135 Thousand EUR | 90.15% |
| 2014 | 92 Thousand EUR | -1102.63% |
| 2013 | -175 Thousand EUR | 69.35% |
| 2012 | 347 Thousand EUR | -409.59% |
| 2011 | -830 Thousand EUR | 98.39% |
| 2010 | -4.69 Million EUR | 4.95% |
| 2009 | -4.76 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 244 Thousand EUR | 0.0% |
| 2023 Q4 | -142 Thousand EUR | 0.0% |
| 2023 Q2 | 1.65 Million EUR | 676129.51% |
| 2023 FY | - EUR | 146.13% |
| 2023 Q1 | 244.00 EUR | 100.03% |
| 2022 Q4 | -699 Thousand EUR | 0.0% |
| 2022 FY | - EUR | -229.79% |
| 2022 Q2 | 753 Thousand EUR | 190.89% |
| 2022 Q1 | -828.5 Thousand EUR | -863.37% |
| 2021 FY | - EUR | 704.23% |
| 2021 Q1 | 369 Thousand EUR | 127.15% |
| 2021 Q2 | 408 Thousand EUR | 10.57% |
| 2021 Q4 | -86 Thousand EUR | 0.0% |
| 2020 Q1 | 40.5 Thousand EUR | 101.87% |
| 2020 Q3 | -1.03 Million EUR | -164.58% |
| 2020 Q2 | -391 Thousand EUR | -1065.43% |
| 2020 Q4 | -1.35 Million EUR | -31.37% |
| 2020 FY | - EUR | 46.88% |
| 2019 FY | - EUR | 73.35% |
| 2019 Q4 | -2.16 Million EUR | -210.98% |
| 2019 Q3 | -696.5 Thousand EUR | -138.12% |
| 2019 Q1 | -292.5 Thousand EUR | 76.55% |
| 2019 Q2 | -292.5 Thousand EUR | 0.0% |
| 2018 Q1 | -533 Thousand EUR | -3.19% |
| 2018 FY | - EUR | -53.08% |
| 2018 Q4 | -1.24 Million EUR | 0.0% |
| 2018 Q3 | -1.24 Million EUR | -134.05% |
| 2018 Q2 | -533 Thousand EUR | 0.0% |
| 2017 FY | - EUR | -6386.49% |
| 2017 Q3 | -516.49 Thousand EUR | 22.51% |
| 2017 Q4 | -516.49 Thousand EUR | 0.0% |
| 2017 Q1 | -666.5 Thousand EUR | -728.77% |
| 2017 Q2 | -666.5 Thousand EUR | 0.0% |
| 2016 FY | - EUR | 72.59% |
| 2016 Q3 | 106 Thousand EUR | -55.37% |
| 2016 Q4 | 106 Thousand EUR | 0.0% |
| 2016 Q1 | 237.5 Thousand EUR | 158.35% |
| 2016 Q2 | 237.5 Thousand EUR | 0.0% |
| 2015 Q2 | -248 Thousand EUR | 0.0% |
| 2015 Q4 | -407 Thousand EUR | 0.0% |
| 2015 Q3 | -407 Thousand EUR | -64.11% |
| 2015 Q1 | -248 Thousand EUR | -555.05% |
| 2015 FY | - EUR | 90.15% |
| 2014 Q4 | 54.5 Thousand EUR | 0.0% |
| 2014 FY | - EUR | -1102.63% |
| 2014 Q3 | 54.5 Thousand EUR | 294.64% |
| 2014 Q1 | -28 Thousand EUR | -107.94% |
| 2014 Q2 | -28 Thousand EUR | 0.0% |
| 2013 Q2 | -111.5 Thousand EUR | 0.0% |
| 2013 Q1 | -111.5 Thousand EUR | 0.0% |
| 2013 FY | - EUR | 69.35% |
| 2013 Q4 | 352.5 Thousand EUR | 0.0% |
| 2013 Q3 | 352.5 Thousand EUR | 416.14% |
| 2012 FY | - EUR | -409.59% |
| 2011 FY | - EUR | 98.39% |
| 2010 FY | - EUR | 4.95% |
| 2009 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Affluent Medical SA | -13.34 Million EUR | 47.111% |
| Bluelinea Société Anonyme | -323.98 EUR | -2178120.569% |
| Carmat SA | -50.45 Million EUR | 86.012% |
| Euromedis Groupe | -4.43 Million EUR | -59.114% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 137.169% |
| Ikonisys S.A. | -2.34 Million EUR | -200.614% |
| Implanet S.A. | -5.07 Million EUR | -38.999% |
| Median Technologies SA | -19.58 Million EUR | 63.967% |
| SpineGuard SA | -3.49 Million EUR | -101.812% |
| Theraclion SA | -4.48 Million EUR | -57.268% |
| Euroapi S.A. | -155.39 Million EUR | 95.459% |
| Guerbet SA | 98.83 Million EUR | 107.14% |
| Ion Beam Applications SA | 12.53 Million EUR | 156.321% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 100.678% |
| Sequana Medical NV | -29.13 Million EUR | 75.78% |